Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2017 (2017), Article ID 5308635, 9 pages
https://doi.org/10.1155/2017/5308635
Review Article

Review of Factors Related to the Thyroid Cancer Epidemic

Department of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan Road 2, Guangzhou, China

Correspondence should be addressed to Haipeng Xiao

Received 6 January 2017; Accepted 12 April 2017; Published 7 May 2017

Academic Editor: Diego Russo

Copyright © 2017 Yihao Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Davies and H. G. Welch, “Current thyroid cancer trends in the United States,” JAMA Otolaryngology. Head & Neck Surgery, vol. 140, no. 4, pp. 317–322, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Chen, R. Zheng, P. D. Baade et al., “Cancer statistics in China, 2015,” CA: a Cancer Journal for Clinicians, vol. 66, no. 2, pp. 115–132, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Dal Maso, M. Lise, P. Zambon et al., “Incidence of thyroid cancer in Italy, 1991-2005: time trends and age-period-cohort effects,” Annals of Oncology, vol. 22, no. 4, pp. 957–963, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. C. C. Lubitz, C. Y. Kong, P. M. McMahon et al., “Annual financial impact of well-differentiated thyroid cancer care in the United States,” Cancer, vol. 120, no. 9, pp. 1345–1352, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Cong, L. W. Fang, H. L. Bao et al., “Disease burden of thyroid cancer in the Chinese population, in 1990 and 2013,” Zhonghua Liu Xing Bing Xue Za Zhi, vol. 37, no. 6, pp. 773–777, 2016. View at Publisher · View at Google Scholar
  6. R. Elisei, “Molecular profiles of papillary thyroid tumors have been changing in the last decades: how could we explain it?” The Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 2, pp. 412–414, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Davies, L. G. Morris, M. Haymart et al., “American Association of Clinical Endocrinologists and American College of Endocrinology disease state clinical review: the increasing incidence of thyroid cancer,” Endocrine Practice, vol. 21, no. 6, pp. 686–696, 2015. View at Publisher · View at Google Scholar
  8. Y. Ito, Y. E. Nikiforov, M. Schlumberger, and R. Vigneri, “Viewpoint: increasing incidence of thyroid cancer: controversies explored,” Nature Reviews Endocrinology, vol. 9, no. 3, pp. 178–184, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Vigneri, P. Malandrino, and P. Vigneri, “The changing epidemiology of thyroid cancer: why is incidence increasing?” Current Opinion in Oncology, vol. 27, no. 1, pp. 1–7, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. C. M. Kitahara and J. A. Sosa, “The changing incidence of thyroid cancer,” Nature Reviews. Endocrinology, vol. 12, no. 11, pp. 646–653, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. H. S. Ahn, H. J. Kim, and H. G. Welch, “Korea’s thyroid-cancer “epidemic”—screening and overdiagnosis,” The New England Journal of Medicine, vol. 371, no. 19, pp. 1765–1767, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. H. S. Ahn and H. G. Welch, “South Korea’s thyroid-cancer “epidemic”—turning the tide,” The New England Journal of Medicine, vol. 373, no. 24, pp. 2389–2390, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. B. L. Sprague, S. W. Andersen, and A. Trentham-Dietz, “Thyroid cancer incidence and socioeconomic indicators of health care access,” Cancer Causes & Control, vol. 19, no. 6, pp. 585–593, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. L. G. Morris, A. G. Sikora, T. D. Tosteson, and L. Davies, “The increasing incidence of thyroid cancer: the influence of access to care,” Thyroid, vol. 23, no. 7, pp. 885–891, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Udelsman and Y. Zhang, “The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds,” Thyroid, vol. 24, no. 3, pp. 472–479, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Gharib, E. Papini, R. Paschke et al., “American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations,” Journal of Endocrinological Investigation, vol. 33, no. 5, pp. 287–291, 2010. View at Publisher · View at Google Scholar
  17. R. Smith-Bindman, D. L. Miglioretti, E. Johnson et al., “Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010,” JAMA, vol. 307, no. 22, pp. 2400–2409, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. G. H. Sun, S. DeMonner, and M. M. Davis, “Epidemiological and economic trends in inpatient and outpatient thyroidectomy in the United States, 1996-2006,” Thyroid, vol. 23, no. 6, pp. 727–733, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. A. B. Ergin, S. Saralaya, and L. Olansky, “Incidental papillary thyroid carcinoma: clinical characteristics and prognostic factors among patients with Graves’ disease and euthyroid goiter, Cleveland clinic experience,” American Journal of Otolaryngology, vol. 35, no. 6, pp. 784–790, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. T. S. Wang, P. Goffredo, J. A. Sosa, and S. A. Roman, “Papillary thyroid microcarcinoma: an over-treated malignancy?” World Journal of Surgery, vol. 38, no. 9, pp. 2297–2303, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. B. R. Haugen, E. K. Alexander, K. C. Bible et al., “2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer,” Thyroid, vol. 26, no. 1, pp. 1–133, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. R. V. Lloyd, L. A. Erickson, M. B. Casey et al., “Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma,” The American Journal of Surgical Pathology, vol. 28, no. 10, pp. 1336–1340, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. H. M. Verkooijen, G. Fioretta, J. C. Pache et al., “Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland,” Cancer Causes & Control, vol. 14, no. 1, pp. 13–17, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. E. Nikiforov, R. R. Seethala, G. Tallini et al., “Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors,” JAMA Oncology, vol. 2, no. 8, pp. 1023–1029, 2016. View at Publisher · View at Google Scholar
  25. H. Lim, S. S. Devesa, J. A. Sosa, D. Check, and C. M. Kitahara, “Trends in thyroid cancer incidence and mortality in the United States, 1974-2013,” JAMA, vol. 317, no. 13, pp. 1338–1348, 2017. View at Publisher · View at Google Scholar
  26. D. Williams, “Radiation carcinogenesis: lessons from Chernobyl,” Oncogene, vol. 27, Supplement 2, pp. S9–S18, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Ron, J. H. Lubin, R. E. Shore et al., “Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. 1995,” Radiation Research, vol. 178, no. 2, pp. AV43–AV60, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Cardis, A. Kesminiene, V. Ivanov et al., “Risk of thyroid cancer after exposure to 131I in childhood,” Journal of the National Cancer Institute, vol. 97, no. 10, pp. 724–732, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Furukawa, D. Preston, S. Funamoto et al., “Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure,” International Journal of Cancer, vol. 132, no. 5, pp. 1222–1226, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. M. N. Nikiforova, J. R. Stringer, R. Blough, M. Medvedovic, J. A. Fagin, and Y. E. Nikiforov, “Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells,” Science, vol. 290, no. 5489, pp. 138–141, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. F. A. Mettler Jr., M. Bhargavan, B. R. Thomadsen et al., “Nuclear medicine exposure in the United States, 2005-2007: preliminary results,” Seminars in Nuclear Medicine, vol. 38, no. 5, pp. 384–391, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Memon, S. Godward, D. Williams, I. Siddique, and K. Al-Saleh, “Dental x-rays and the risk of thyroid cancer: a case-control study,” Acta Oncologica, vol. 49, no. 4, pp. 447–453, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. C. K. Jung, M. P. Little, J. H. Lubin et al., “The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations,” The Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 2, pp. E276–E285, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Romei, L. Fugazzola, E. Puxeddu et al., “Modifications in the papillary thyroid cancer gene profile over the last 15 years,” The Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 9, pp. E1758–E1765, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. J. G. Fortner, P. A. George, and S. S. Sternberg, “Induced and spontaneous thyroid cancer in the Syrian (golden) hamster,” Endocrinology, vol. 6, pp. 364–376, 1960. View at Publisher · View at Google Scholar
  36. R. T. Schaller Jr and J. K. Stevenson, “Development of carcinoma of the thyroid in iodine-deficient mice,” Cancer, vol. 19, no. 8, pp. 1063–1080, 1966. View at Publisher · View at Google Scholar
  37. J. Xiang, X. Wang, Z. Wang et al., “Effect of different iodine concentrations on well-differentiated thyroid cancer cell behavior and its inner mechanism,” Cell Biochemistry and Biophysics, vol. 71, no. 1, pp. 299–305, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Clero, F. Doyon, V. Chungue et al., “Dietary iodine and thyroid cancer risk in French Polynesia: a case-control study,” Thyroid, vol. 22, no. 4, pp. 422–429, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. U. Feldt-Rasmussen, “Iodine and cancer,” Thyroid, vol. 11, no. 5, pp. 483–486, 2001. View at Publisher · View at Google Scholar
  40. L. N. Kolonel, J. H. Hankin, L. R. Wilkens, F. H. Fukunaga, and M. W. Hinds, “An epidemiologic study of thyroid cancer in Hawaii,” Cancer Causes & Control, vol. 1, no. 3, pp. 223–234, 1990. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Knobel and G. Medeiros-Neto, “Relevance of iodine intake as a reputed predisposing factor for thyroid cancer,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 51, no. 5, pp. 701–712, 2007. View at Publisher · View at Google Scholar
  42. W. Dong, H. Zhang, P. Zhang et al., “The changing incidence of thyroid carcinoma in Shenyang, China before and after universal salt iodization,” Medical Science Monitor, vol. 19, pp. 49–53, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. W. Teng, Z. Shan, X. Teng et al., “Effect of iodine intake on thyroid diseases in China,” The New England Journal of Medicine, vol. 354, no. 26, pp. 2783–2793, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. Z. Shan, L. Chen, X. Lian et al., “Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 16 years in China: a cross-sectional study in 10 cities,” Thyroid, vol. 26, no. 8, pp. 1125–1130, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Sehestedt, N. Knudsen, H. Perrild, and C. Johansen, “Iodine intake and incidence of thyroid cancer in Denmark,” Clinical Endocrinology, vol. 65, no. 2, pp. 229–233, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. C. S. Fuziwara and E. T. Kimura, “High iodine blocks a Notch/miR-19 loop activated by the BRAF(V600E) oncoprotein and restores the response to TGFbeta in thyroid follicular cells,” Thyroid, vol. 24, no. 3, pp. 453–462, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Guan, M. Ji, R. Bao et al., “Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer,” The Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 5, pp. 1612–1617, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. R. Bubenhofer and C. Hedinger, “Thyroid neoplasms before and after the prophylactic supplementation of table salt with iodine,” Schweizerische Medizinische Wochenschrift, vol. 107, no. 21, pp. 733–741, 1977. View at Google Scholar
  49. E. D. Williams, I. Doniach, O. Bjarnason, and W. Michie, “Thyroid cancer in an iodide rich area: a histopathological study,” Cancer, vol. 39, no. 1, pp. 215–222, 1977. View at Publisher · View at Google Scholar
  50. D. Schmid, G. Behrens, C. Jochem, M. Keimling, and M. Leitzmann, “Physical activity, diabetes, and risk of thyroid cancer: a systematic review and meta-analysis,” European Journal of Epidemiology, vol. 28, no. 12, pp. 945–958, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. C. M. Kitahara, E. A. Platz, L. E. Freeman et al., “Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies,” Cancer Epidemiology, Biomarkers & Prevention, vol. 20, no. 3, pp. 464–472, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Ma, M. Huang, L. Wang, W. Ye, Y. Tong, and H. Wang, “Obesity and risk of thyroid cancer: evidence from a meta-analysis of 21 observational studies,” Medical Science Monitor, vol. 21, pp. 283–291, 2015. View at Publisher · View at Google Scholar · View at Scopus
  53. A. G. Renehan, M. Tyson, M. Egger, R. F. Heller, and M. Zwahlen, “Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies,” Lancet, vol. 371, no. 9612, pp. 569–578, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. C. M. Kitahara, G. Neta, R. M. Pfeiffer et al., “Common obesity-related genetic variants and papillary thyroid cancer risk,” Cancer Epidemiology, Biomarkers & Prevention, vol. 21, no. 12, pp. 2268–2271, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Fang, B. Yao, Y. Yan et al., “Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies,” Diabetes Technology & Therapeutics, vol. 15, no. 11, pp. 914–922, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. C. Haggstrom, M. Van Hemelrijck, B. Zethelius et al., “Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs, and risk of prostate cancer,” International Journal of Cancer, vol. 140, no. 3, pp. 611–617, 2016. View at Publisher · View at Google Scholar
  57. C. H. Tseng, C. K. Chong, and T. Y. Tai, “Secular trend for mortality from breast cancer and the association between diabetes and breast cancer in Taiwan between 1995 and 2006,” Diabetologia, vol. 52, no. 2, pp. 240–246, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. S. E. Holden, “Diabetes and cancer,” Endocrine Development, vol. 31, pp. 135–145, 2016. View at Publisher · View at Google Scholar · View at Scopus
  59. Z. G. Zhao, X. G. Guo, C. X. Ba et al., “Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies,” The Journal of International Medical Research, vol. 40, no. 6, pp. 2041–2050, 2012. View at Publisher · View at Google Scholar
  60. K. D. Bertakis and R. Azari, “Obesity and the use of health care services,” Obesity Research, vol. 13, no. 2, pp. 372–379, 2005. View at Publisher · View at Google Scholar
  61. J. Luo, L. Phillips, S. Liu, J. Wactawski-Wende, and K. L. Margolis, “Diabetes, diabetes treatment, and risk of thyroid cancer,” The Journal of Clinical Endocrinology and Metabolism, vol. 101, no. 3, pp. 1243–1248, 2016. View at Publisher · View at Google Scholar · View at Scopus
  62. B. Aschebrook-Kilfoy, M. M. Sabra, A. Brenner et al., “Diabetes and thyroid cancer risk in the National Institutes of Health-AARP Diet and Health Study,” Thyroid, vol. 21, no. 9, pp. 957–963, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. K. Pazaitou-Panayiotou, S. A. Polyzos, and C. S. Mantzoros, “Obesity and thyroid cancer: epidemiologic associations and underlying mechanisms,” Obesity Reviews, vol. 14, no. 12, pp. 1006–1022, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. R. J. Santen, W. Yue, and J. P. Wang, “Estrogen metabolites and breast cancer,” Steroids, vol. 99, Part A, pp. 61–66, 2015. View at Publisher · View at Google Scholar · View at Scopus
  65. K. A. Ashton, A. Proietto, G. Otton et al., “Estrogen receptor polymorphisms and the risk of endometrial cancer,” BJOG, vol. 116, no. 8, pp. 1053–1061, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. D. Gallo, C. Ferlini, and G. Scambia, “The epithelial-mesenchymal transition and the estrogen-signaling in ovarian cancer,” Current Drug Targets, vol. 11, no. 4, pp. 474–481, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. F. Magri, V. Capelli, M. Rotondi et al., “Expression of estrogen and androgen receptors in differentiated thyroid cancer: an additional criterion to assess the patient’s risk,” Endocrine-Related Cancer, vol. 19, no. 4, pp. 463–471, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Kamat, S. Rajoria, A. George et al., “Estrogen-mediated angiogenesis in thyroid tumor microenvironment is mediated through VEGF signaling pathways,” Archives of Otolaryngology – Head & Neck Surgery, vol. 137, no. 11, pp. 1146–1153, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. S. Rajoria, R. Suriano, A. George et al., “Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3′-diindolylmethane in thyroid cancer,” PLoS One, vol. 6, no. 1, article e15879, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Rajoria, R. Suriano, A. Shanmugam et al., “Metastatic phenotype is regulated by estrogen in thyroid cells,” Thyroid, vol. 20, no. 1, pp. 33–41, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. Y. Lu, J. Li, and J. Li, “Estrogen and thyroid diseases: an update,” Minerva Medica, vol. 107, no. 4, pp. 239–244, 2016. View at Google Scholar
  72. M. Zahid, W. Goldner, C. L. Beseler, E. G. Rogan, and E. L. Cavalieri, “Unbalanced estrogen metabolism in thyroid cancer,” International Journal of Cancer, vol. 133, no. 11, pp. 2642–2649, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. J. H. Kuo, J. A. Chabot, and J. A. Lee, “Breast cancer in thyroid cancer survivors: an analysis of the surveillance, epidemiology, and end results-9 database,” Surgery, vol. 159, no. 1, pp. 23–29, 2016. View at Publisher · View at Google Scholar · View at Scopus
  74. J. Luo, M. Hendryx, J. E. Manson, X. Liang, and K. L. Margolis, “Hysterectomy, oophorectomy, and risk of thyroid cancer,” The Journal of Clinical Endocrinology and Metabolism, vol. 101, no. 10, pp. 3812–3819, 2016. View at Publisher · View at Google Scholar
  75. Y. Lun, X. Wu, Q. Xia et al., “Hashimoto’s thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis,” Otolaryngology and Head and Neck Surgery, vol. 148, no. 3, pp. 396–402, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. M. Khatami, “Inflammation, aging, and cancer: tumoricidal versus tumorigenesis of immunity: a common denominator mapping chronic diseases,” Cell Biochemistry and Biophysics, vol. 55, no. 2, pp. 55–79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. H. Ma, J. Yan, C. Zhang et al., “Expression of papillary thyroid carcinoma-associated molecular markers and their significance in follicular epithelial dysplasia with papillary thyroid carcinoma-like nuclear alterations in Hashimoto’s thyroiditis,” International Journal of Clinical and Experimental Pathology, vol. 7, no. 11, pp. 7999–8007, 2014. View at Google Scholar
  78. K. Mukasa, J. Y. Noh, Y. Kunii et al., “Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases,” Thyroid, vol. 21, no. 1, pp. 37–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. C. Anil, S. Goksel, and A. Gursoy, “Hashimoto’s thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: a single-center prospective study,” Thyroid, vol. 20, no. 6, pp. 601–6, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. G. Shen, T. Ji, S. Hu, B. Liu, and A. Kuang, “Coexistence of papillary thyroid carcinoma with thyroid MALT lymphoma in a patient with Hashimoto’s thyroiditis: a clinical case report,” Medicine (Baltimore), vol. 94, no. 52, article e2403, 2015. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Erdogan, N. Erdem, S. Cetinkalp et al., “Demographic, clinical, laboratory, ultrasonographic, and cytological features of patients with Hashimoto’s thyroiditis: results of a university hospital of 769 patients in Turkey,” Endocrine, vol. 36, no. 3, pp. 486–490, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. E. H. Siriweera and N. V. Ratnatunga, “Profile of Hashimoto’s thyroiditis in Sri Lankans: is there an increased risk of ancillary pathologies in Hashimoto’s thyroiditis?” Journal of Thyroid Research, vol. 2010, Article ID 124264, p. 5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. O. Kurukahvecioglu, F. Taneri, O. Yuksel, A. Aydin, E. Tezel, and E. Onuk, “Total thyroidectomy for the treatment of Hashimoto’s thyroiditis coexisting with papillary thyroid carcinoma,” Advances in Therapy, vol. 24, no. 3, pp. 510–516, 2007. View at Publisher · View at Google Scholar · View at Scopus
  84. S. D. Larson, L. N. Jackson, T. S. Riall et al., “Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway,” Journal of the American College of Surgeons, vol. 204, no. 5, pp. 764–773, 2007, discussion 773-5. View at Publisher · View at Google Scholar · View at Scopus
  85. C. Cipolla, L. Sandonato, G. Graceffa et al., “Hashimoto thyroiditis coexistent with papillary thyroid carcinoma,” The American Surgeon, vol. 71, no. 10, pp. 874–878, 2005. View at Google Scholar
  86. E. E. Mazokopakis, A. A. Tzortzinis, E. I. Dalieraki-Ott et al., “Coexistence of Hashimoto’s thyroiditis with papillary thyroid carcinoma. A retrospective study,” Hormones (Athens, Greece), vol. 9, no. 4, pp. 312–317, 2010. View at Publisher · View at Google Scholar
  87. B. Jankovic, K. T. Le, and J. M. Hershman, “Clinical review: Hashimoto’s thyroiditis and papillary thyroid carcinoma: is there a correlation?” The Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 2, pp. 474–482, 2013. View at Publisher · View at Google Scholar · View at Scopus
  88. S. D. Gangolli, P. A. van den Brandt, V. J. Feron et al., “Nitrate, nitrite and N-nitroso compounds,” European Journal of Pharmacology, vol. 292, no. 1, pp. 1–38, 1994. View at Publisher · View at Google Scholar · View at Scopus
  89. G. M. McKnight, C. W. Duncan, C. Leifert, and M. H. Golden, “Dietary nitrate in man: friend or foe?” The British Journal of Nutrition, vol. 81, no. 5, pp. 349–358, 1999. View at Publisher · View at Google Scholar
  90. L. Cherrat, L. Espina, M. Bakkali, D. García-Gonzalo, R. Pagán, and A. Laglaoui, “Chemical composition and antioxidant properties of Laurus nobilis L. and Myrtus communis L. essential oils from Morocco and evaluation of their antimicrobial activity acting alone or in combined processes for food preservation,” Journal of the Science of Food and Agriculture, vol. 94, no. 6, pp. 1197–1204, 2014. View at Publisher · View at Google Scholar · View at Scopus
  91. Y. Hiasa, Y. Kitahori, M. Kitamura et al., “Relationships between serum thyroid stimulating hormone levels and development of thyroid tumors in rats treated with N-bis-(2-hydroxypropyl)nitrosamine,” Carcinogenesis, vol. 12, no. 5, pp. 873–877, 1991. View at Publisher · View at Google Scholar · View at Scopus
  92. M. H. Ward, B. A. Kilfoy, P. J. Weyer, K. E. Anderson, A. R. Folsom, and J. R. Cerhan, “Nitrate intake and the risk of thyroid cancer and thyroid disease,” Epidemiology, vol. 21, no. 3, pp. 389–395, 2010. View at Publisher · View at Google Scholar · View at Scopus
  93. B. A. Kilfoy, Y. Zhang, Y. Park et al., “Dietary nitrate and nitrite and the risk of thyroid cancer in the NIH-AARP Diet and Health Study,” International Journal of Cancer, vol. 129, no. 1, pp. 160–172, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. A. McTiernan, C. Ulrich, S. Slate, and J. Potter, “Physical activity and cancer etiology: associations and mechanisms,” Cancer Causes & Control, vol. 9, no. 5, pp. 487–509, 1998. View at Publisher · View at Google Scholar · View at Scopus
  95. J. P. Russell, J. B. Engiles, and J. L. Rothstein, “Proinflammatory mediators and genetic background in oncogene mediated tumor progression,” Journal of Immunology, vol. 172, no. 7, pp. 4059–4067, 2004. View at Publisher · View at Google Scholar
  96. A. A. Samani, S. Yakar, D. LeRoith, and P. Brodt, “The role of the IGF system in cancer growth and metastasis: overview and recent insights,” Endocrine Reviews, vol. 28, no. 1, pp. 20–47, 2007. View at Publisher · View at Google Scholar · View at Scopus
  97. C. M. Ulrich, J. Wiskemann, and K. Steindorf, “Physiologic and molecular mechanisms linking physical activity to cancer risk and progression,” Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, vol. 55, no. 1, pp. 3–9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. C. Xhaard, J. J. Lence-Anta, Y. Ren et al., “Recreational physical activity and differentiated thyroid cancer risk: a pooled analysis of two case-control studies,” European Thyroid Journal, vol. 5, no. 2, pp. 132–138, 2016. View at Publisher · View at Google Scholar
  99. C. M. Kitahara, M. S. Linet, L. E. Beane Freeman et al., “Cigarette smoking, alcohol intake, and thyroid cancer risk: a pooled analysis of five prospective studies in the United States,” Cancer Causes & Control, vol. 23, no. 10, pp. 1615–1624, 2012. View at Publisher · View at Google Scholar · View at Scopus
  100. O. P. Soldin, B. E. Goughenour, S. Z. Gilbert, H. J. Landy, and S. J. Soldin, “Thyroid hormone levels associated with active and passive cigarette smoking,” Thyroid, vol. 19, no. 8, pp. 817–823, 2009. View at Publisher · View at Google Scholar · View at Scopus
  101. O. P. Soldin, K. H. Makambi, S. J. Soldin, and D. M. O’Mara, “Steroid hormone levels associated with passive and active smoking,” Steroids, vol. 76, no. 7, pp. 653–659, 2011. View at Publisher · View at Google Scholar · View at Scopus
  102. Cancer Genome Atlas Research Network, “Integrated genomic characterization of papillary thyroid carcinoma,” Cell, vol. 159, no. 3, pp. 676–690, 2014. View at Publisher · View at Google Scholar · View at Scopus
  103. M. J. Jeon, W. G. Kim, Y. M. Choi et al., “Features predictive of distant metastasis in papillary thyroid microcarcinomas,” Thyroid, vol. 26, no. 1, pp. 161–168, 2016. View at Publisher · View at Google Scholar · View at Scopus